Our Services

We deliver advanced tests and research that support better health for all. We deliver advanced tests and research that support better health for all.

Get Started

Consultancy services

We deliver faster R&D by laser focus target identification for our customer to make true difference in biomedicine.

Diagnostic Kit Development for Infectious Diseases:

We provide comprehensive support for the development of high‑performance diagnostic kits targeting viral, bacterial, and emerging infectious diseases. Our approach integrates molecular biology, assay engineering, and regulatory‑aligned design principles to help clients bring accurate, reliable, and scalable diagnostic solutions to market.

Our scientist, Dr. Subhra Chakraborty has established the Rapid Loop-mediated Isothermal Amplification (RLDT) diagnostic assay, a cutting-edge tool designed for the swift and sensitive detection of Enterotoxigenic E. coli (ETEC) and Shigella directly from fecal samples. The RLDT platform stands out for its suitability in low-resource settings, as it eliminates the need for a cold chain or electricity, making it highly accessible in endemic regions where these pathogens are prevalent. The method is remarkably straightforward, requiring only minimal equipment, and delivers reliable results in under an hour. This efficiency and simplicity make RLDT an invaluable solution for rapid diagnosis and disease management in resource-constrained environments.

Assay Development &
Analytical Strategy Services

Our consultancy delivers end‑to‑end assay development support tailored for biologics, and advanced therapeutic programs. We partner with clients to design, optimize, validate, and document high‑quality analytical methods that accelerate program readiness and ensure regulatory confidence.

Core Service Areas

(i) Assay Design & Method Development

  • Development of molecular, cellular, and biochemical assays aligned with program goals
  • Design of potency, identity, purity, and safety assays for early‑stage and IND‑enabling studies
  • Optimization of assay parameters to ensure robustness, sensitivity, and reproducibility
  • Troubleshooting and refinement of existing assays to improve performance and reduce variability

(ii) Method Qualification & Validation

  • Authoring, reviewing, and approving assay qualification and validation protocols
  • Execution oversight and scientific guidance for validation studies
  • Alignment with ICH, FDA, and industry best practices for analytical lifecycle management
  • Comprehensive post‑execution review, data curation, and final approval support

(iii) Specialized Cell & Gene Therapy Analytics

  • ddPCR assay development and validation for vector copy number, potency, and biodistribution
  • HPLC‑based methods for purity, identity, and product characterization
  • Multi‑omics‑informed analytical strategies for complex biological systems
  • Support for viral vector, mRNA, plasmid DNA, and cell‑based therapeutic platforms

(iv) Strategic Analytical Consulting

  • Analytical gap assessments and roadmap development
  • Data interpretation, trend analysis, and decision‑ready reporting
  • Integration of analytical strategy with programming milestones and risk mitigation plans
  • Ongoing scientific advisory support for fast‑moving development teams

Consultancy on Targeted Approach for Gastrointestinal, Renal, and lung diseases

Our consultancy delivers specialized support for clients seeking solutions in gastrointestinal, renal, and respiratory (lung) diseases. Our target approach combines scientific rigor, translational research, and practical solutions to accelerate the development of diagnostics and therapeutics for complex diseases. We partner with clients from concept to implementation, ensuring that each project is tailored to specific clinical and regulatory needs.

Leveraging advanced scientific expertise, we offer:

  • Gastrointestinal Diseases:
    We provide guidance on disease mechanisms, diagnostic strategies, and therapeutic interventions for a wide range of gastrointestinal disorders. Our approach integrates the latest research in diet-induced animal models and systemic disease pathways to help clients develop targeted treatments and diagnostic tools.
  • Renal Diseases:
    Our team offers expertise in renal pathology, focusing on innovative diagnostic and therapeutic strategies for kidney-related diseases. We assist clients in designing studies, developing animal models, and implementing evidence-based interventions to improve renal health outcomes.
  • Lung Diseases:
    We support clients in addressing respiratory diseases through comprehensive research, diagnostic kit development, and clinical trial design. Our consultants specialize in the identification of disease biomarkers, assay development, and the creation of rapid diagnostic platforms suitable for resource-limited settings.

Consultancy on Targeted Approach for Infectious Diseases

Our consultancy provides comprehensive support for the development of high-performance diagnostic kits and solutions targeting viral, bacterial, and emerging infectious diseases. We integrate molecular biology, assay engineering, and regulatory-aligned design principles to help clients bring accurate, reliable, and scalable diagnostic solutions to market. Our approach emphasizes rapid, sensitive detection methods suitable for resource-limited settings, ensuring accessibility and impact in endemic regions.

We partner with clients from concept to implementation, offering expertise in disease mechanisms, diagnostic strategy development, and clinical trial design. Our consultants specialize in the identification of disease biomarkers, assay development, and the creation of innovative diagnostic platforms tailored to specific clinical and regulatory needs.

Consultancy on Targeted Approach for Systemic Diseases

Our consultancy provides specialized support for clients seeking solutions to systemic diseases, including hyperlipidemia, hyperuricemia, and diabetes. Our approach ensures that each project is customized to meet specific clinical and regulatory needs, guiding clients from concept to implementation for impactful results We combine scientific rigor, translational research, and practical strategies to accelerate the development of diagnostics and therapeutics for these complex conditions.

  • Hyperlipidemia:
    We offer guidance on lipid metabolism, risk assessment, and therapeutic interventions. Our team assists clients in designing studies, developing animal models, and implementing evidence-based approaches to improve cardiovascular outcomes.
  • Hyperuricemia:
    Our experts focus on innovative diagnostic and management strategies for elevated uric acid levels and related complications. We support clients in developing targeted interventions and monitoring protocols to reduce disease burden.
  • Diabetes:
    We provide comprehensive support for diabetes research and management, including biomarker identification, assay development, and clinical trial design. Our consultants help clients create tailored solutions for early detection, monitoring, and therapeutic optimization.

Consultancy on Targeted Approach for Neuronal and Rare Diseases

Our consultancy provides specialized support for clients seeking solutions to neuronal and rare diseases, with a particular focus on Alzheimer’s disease (AD), Parkinson’s disease (PD), and depression. We combine scientific rigor, translational research, and practical strategies to accelerate the development of diagnostics and therapeutics for these complex neurological conditions.

  • Alzheimer’s Disease (AD):
    We offer expertise in the mechanisms underlying neurodegeneration and therapeutic interventions for Alzheimer’s disease. Our team assists clients in designing studies, developing animal models, and implementing evidence-based approaches for early detection and treatment optimization.
  • Parkinson’s Disease (PD):
    Our consultants provide guidance on the pathophysiology, biomarker identification, and therapeutic strategies for Parkinson’s disease. We support clients in developing targeted interventions and monitoring protocols to improve patient outcomes.
  • Depression and Rare Neurological Disorders:
    We deliver comprehensive support for research and management of depression and other rare neurological conditions, including assay development, clinical trial design, and therapeutic innovation.

Consultancy on Targeted Approach for Clinical Trials and Data Management

Our consultancy offers comprehensive support for clinical research, ensuring robust study design, reliable data collection, and insightful analysis:

  • Clinical Trial Designing:
    We provide expert guidance in designing clinical trials tailored to specific research objectives and regulatory requirements. Our team ensures that protocols are scientifically rigorous, ethically sound, and optimized for successful outcomes.
  • Statistical Analysis of Clinical Trial Data:
    Our consultants specialize in advanced statistical analysis, transforming raw clinical data into actionable insights. We apply appropriate statistical methodologies to ensure data integrity, validity, and compliance with regulatory standards.
  • Data Collection Tool Development:
    We develop and customize data collection tools that streamline field studies and clinical research. Our solutions are designed for accuracy, efficiency, and ease of use, supporting high-quality data acquisition across diverse study environments.
  • Site Selection:
    We assist clients in identifying and selecting optimal study sites based on project needs, patient populations, and logistical considerations. Our approach maximizes recruitment potential and operational efficiency for clinical trials.

Higher learning & teaching services

A premium, knowledge‑driven offering that elevates client capability, scientific rigor, and translational impact. We strengthen the value proposition by offering higher‑learning and teaching services that empower clients—biotech teams, pharma groups, academic labs, and clinical research units—to build deep scientific competence while accelerating R&D outcomes.

Core offerings

  • Targeted disease‑area masterclasses (systemic, neuronal, rare, infectious, GI/renal/lung diseases)
  • Workshops on assay development, analytical strategy, and method validation
  • Deep‑dive sessions on cell & gene therapy analytics (ddPCR, HPLC, multi‑omics)
  • Translational science seminars linking mechanisms to diagnostics and therapeutics

Outcome:

Clients gain the scientific literacy needed to make faster, more confident R&D decisions.

Scientific Literature Search & Evidence Synthesis:

Accelerate your R&D and decision-making with fast, rigorous, and expertly curated scientific intelligence. Our Scientific Literature Search & Evidence Synthesis service delivers high-quality, decision-ready insights drawn from peer-reviewed publications, regulatory documents, clinical trial databases, and emerging scientific sources. We combine domain expertise with structured evidence-mapping to help you navigate complex biomedical questions with clarity and confidence.

What This Service Provides

  • Targeted Literature Search Systematic, reproducible searches across PubMed, Scopus, Web of Science, ClinicalTrials.gov, FDA/EMA databases, and more.
  • Data Extraction & Evidence Mapping Structured extraction of study design, methods, endpoints, biomarkers, assays, and key findings.
  • Synthesis & Insight Generation Clear, concise summaries that highlight consensus, contradictions, knowledge gaps, and translational relevance.
  • Strategic Recommendations Actionable guidance aligned with your R&D, assay development, regulatory, or clinical objectives.

Ideal For

  • Early-stage discovery teams validating targets or biomarkers
  • Translational research groups evaluating assay platforms
  • Clinical development teams assessing endpoints or comparators
  • Regulatory teams preparing scientific justifications
  • Investors or due-diligence teams evaluating scientific feasibility